We did not observe statistically significant MTA elevation in GBM tumors with low MTAP expression compared to those with high MTAP expression or GBM tumors with frequent MTAP deletions and grade 2 and 3 glioma tumors with rare MTAP deletions. This evidence concerns the gene MTAP and central nervous system cancer.